Meet the Scientific Team

Peter Lansdorp, MD, PhD, Co-Founder and Chief Scientific Officer

Peter Lansdorp, MD, PhD

Co-Founder and Chief Scientific Officer

Peter Lansdorp and his research team at the Terry Fox laboratory of the BC Cancer Agency developed and perfected the Flow FISH procedure at a time when his research was mainly focused on telomere biology. This knowledge and technology were successfully translated to licensed and validated clinical testing service with RepeatDx in 2008. Peter is a Distinguished Scientist at the BC Cancer Agency and a Professor in Medical Genetics at the University of British Columbia. He studied medicine at Erasmus University Rotterdam and gained his PhD at the University of Amsterdam, The Netherlands. His current research work focuses on genome analysis and the role of genetic instability in ageing and cancer.

Audi Setiadi MD, FRCPC, Medical Director

Audi Setiadi MD, FRCPC

Medical Director

Audi Setiadi was appointed Medical Director of Repeat Dx in 2025 and is responsible for RDx clinical testing activities. Audi is a Hematopathologist, medical director of the Flow Cytometry & Cellular Therapy Laboratories at BC Children’s Hospital, and Clinical Associate Professor at University of British Columbia (UBC) in Vancouver, Canada. Her areas of expertise include flow cytometry for immunodeficiency disorders and hematologic malignancies. She served as an expert panel committee member for the development of CLSI (Clinical and Laboratory Standards Institute) standards on Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells (3rd ed.). She has given many lectures at national and international levels, including International Clinical Cytometry Society (ICCS) conferences. She brings to Repeat Dx her clinical laboratory leadership, as well as her experience in Hematopathology, and translational research fields.

Geraldine Aubert, PhD, Director of Clinical Development & Research

Geraldine Aubert, PhD

Director of Clinical Development & Research

Geraldine Aubert was appointed Director of Clinical Development & Research of RepeatDx in 2011. She is responsible for the scientific oversight of clinical testing activities of the RepeatDx laboratory as well as the clinical quality and regulatory affairs programs. Geraldine is a Staff Scientist at the BC Cancer Agency Terry Fox laboratory; her research work is related to molecular and cellular factors that influence the length of telomeres and to human disease mediated by telomere biology. She obtained a degree in Medical Biology and Biochemistry in Dijon, France prior to a PhD in Hematology from University College London, United Kingdom. She brings to RepeatDx her scientific laboratory leadership, telomere biology knowledge and academic research and knowledge translation expertise.

Elmira Hariri,

Elmira Hariri

Elmira Hariri brings her scientific laboratory leadership, telomere biology knowledge and academic research and knowledge translation expertise.

Technologists

RepeatDx’s Laboratory is staffed by a group of Technologists registered with the College of Medical Laboratory Technologists. They are dedicated to helping physicians around the world make accurate diagnoses through analysis of telomeres.